Ivonescimab versus pembrolizumab for PD-L1-positive non-small cell lung cancer (HARMONi-2): a randomised, double-blind, phase 3 study in China

Anwen Xiong, Lei Wang, Jianhua Chen, +42

The Lancet

MedicineImmunologyPathologyImmune Checkpoint InhibitorCancer Treatment +4

Quercetin attenuates renal ischemia/reperfusion injury via an activation of AMP-activated protein kinase-regulated autophagy pathway

Bolin Chen, Liting Wang, Kuo‐How Huang, +3

The Journal of Nutritional Biochemistry

InflammationCell AutophagyMitophagyMedicinePhysiology +9

Single-Cell RNA-Seq Analysis Reveals Macrophage Involved in the Progression of Human Intervertebral Disc Degeneration

Zemin Ling, Yong Liu, Zhe Wang, +10

Frontiers in Cell and Developmental Biology

Protective Role of AMP-Activated Protein Kinase-Evoked Autophagy on an In Vitro Model of Ischemia/Reperfusion-Induced Renal Tubular Cell Injury

Liting Wang, Bolin Chen, Cheng‐Tien Wu, +3

PLoS ONE

MitophagyApoptosisImmunologyCell DeathCellular Physiology +22

Peripheral Blood Biomarkers Associated With Outcome in Non-small Cell Lung Cancer Patients Treated With Nivolumab and Durvalumab Monotherapy

Meilin Jiang, Wenying Peng, Xingxiang Pu, +11

Frontiers in Oncology

Inhibition of Pim-1 Kinase Ameliorates Dextran Sodium Sulfate-Induced Colitis in Mice

Yueming Shen, Yan Zhao, Ya Zeng, +5

Digestive Diseases and Sciences

InflammationAnti-inflammatoryMucosal ImmunologyMedicineImmunology +5

A phase Ib/II study of cadonilimab (PD-1/CTLA-4 bispecific antibody) plus anlotinib as first-line treatment in patients with advanced non-small cell lung cancer

Bolin Chen, Wenxiu Yao, Xingya Li, +21

British Journal of Cancer

MedicineImmunologyBronchial NeoplasmImmune Checkpoint InhibitorFirst-line Treatment +6

Dacomitinib induces objective responses in metastatic brain lesions of patients with EGFR-mutant non-small-cell lung cancer: A brief report

Wenying Peng, Xingxiang Pu, Meilin Jiang, +10

Lung Cancer

Genomic and molecular landscape of homologous recombination deficiency across multiple cancer types

Zhiwen Shi, Bolin Chen, Xiao Han, +3

Scientific Reports

Clinical and genomic features of Chinese lung cancer patients with germline mutations

Wenying Peng, Bin Li, Jin Li, +23

Nature Communications